Mark Elliott Boulding Insider Trading for July 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark Elliott Boulding.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Mark Elliott Boulding for July 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | M | 18.01 | 17,500 | 315,175 | 26,250 | |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | M | 11.23 | 13,125 | 147,394 | 6,563 | |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 55.73 | 100 | 5,573 | 39,724 | 39.8 K to 39.7 K (-0.25 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 55.24 | 3,675 | 203,011 | 39,824 | 43.5 K to 39.8 K (-8.45 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 54.20 | 600 | 32,517 | 43,499 | 44.1 K to 43.5 K (-1.36 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 55.74 | 400 | 22,295 | 44,099 | 44.5 K to 44.1 K (-0.90 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 55.23 | 7,350 | 405,955 | 44,499 | 51.8 K to 44.5 K (-14.18 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 54.20 | 1,000 | 54,202 | 51,849 | 52.8 K to 51.8 K (-1.89 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 55.26 | 3,775 | 208,591 | 52,849 | 56.6 K to 52.8 K (-6.67 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 54.20 | 600 | 32,517 | 56,624 | 57.2 K to 56.6 K (-1.05 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Buy | M | 18.01 | 17,500 | 315,175 | 57,224 | 39.7 K to 57.2 K (+44.05 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 55.73 | 200 | 11,146 | 39,724 | 39.9 K to 39.7 K (-0.50 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 55.23 | 4,301 | 237,536 | 39,924 | 44.2 K to 39.9 K (-9.73 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 54.18 | 626 | 33,916 | 44,225 | 44.9 K to 44.2 K (-1.40 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 55.24 | 2,881 | 159,144 | 44,851 | 47.7 K to 44.9 K (-6.04 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 54.15 | 400 | 21,659 | 47,732 | 48.1 K to 47.7 K (-0.83 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 55.73 | 100 | 5,573 | 48,132 | 48.2 K to 48.1 K (-0.21 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 55.22 | 2,824 | 155,953 | 48,232 | 51.1 K to 48.2 K (-5.53 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 54.11 | 357 | 19,317 | 51,056 | 51.4 K to 51.1 K (-0.69 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 55.31 | 962 | 53,205 | 51,413 | 52.4 K to 51.4 K (-1.84 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 54.70 | 474 | 25,927 | 52,375 | 52.8 K to 52.4 K (-0.90 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Buy | M | 11.23 | 13,125 | 147,394 | 52,849 | 39.7 K to 52.8 K (+33.04 %) |